|Articles|December 17, 2009

Pomegranate Latest Weapon to Fight MRSA

Scientists have discovered that pomegranate rinds combined with two natural products can be turned into an ointment for treating MRSA (Methicillin-Resistant Staphylococcus aureus) and other common hospital infections.

KINGSTON, United Kingdom—Scientists have discovered that pomegranate rinds combined with two natural products can be turned into an ointment for treating MRSA (Methicillin-Resistant Staphylococcus aureus) and other common hospital infections.

Researchers from the University of Kingston’s School of Life Sciences discovered that the infection-fighting properties of pomegranate were greatly enhanced by combining the rind of the fruit with metal salts and vitamin C. Pomegranate rind combined with metal salts was the most effective combination for treating MRSA, while other common hospital infections were better dealt with by all three components—pomegranate rind, metal salts and vitamin C.

"We have developed a topical ointment that can successfully attack a range of drug resistant microbes. It's a significant breakthrough and a striking example of the effectiveness of adding more components to create a more active product," Professor Declan Naughton said. "It shows that nature still has a few tricks up its sleeve. The idea of using a foodstuff is unusual and means that the body should be able to cope more easily with its application; patients are less likely to experience any major side-effects."


Related to this article

Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.